Wuxi Biologics (Cayman) Overview

Wuxi Biologics (Cayman) Selling, General & Admin

Selling, General & Admin expenses for WXXWY.

Quarterly SG&A Expenses

$1.31B

↑ 36.22% YoY

As of Dec 31, 2025

Annual SG&A Expenses (TTM)

$4.64B

↑ 22.83% YoY

Trailing 12 months ending Dec 31, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin